Close Lucintel Chat
Didn't Find What You're Looking for?
Call us at +1972 636 5056 or write at helpdesk@Lucintel.com
Ask an Expert Provide Custom Requirements Download Sample Report Search Available Reports
  • helpdesk@Lucintel.com
  • |
  • Call Lucintel +1 972 636 5056
  • |
  • Login
  • |
  • Register
  • |
  • Search
  • |
'
...

The Impact of COVID-19 is included in Chikungunya Vaccine Market Report. Buy it today to get an advantage.

Request the impact of COVID-19 on your product or industry


Chikungunya Vaccine Trends and Forecast

The future of the global chikungunya vaccine market looks promising with opportunities in the hospital pharmacy and retail pharmacy markets. The global chikungunya vaccine market is expected to reach an estimated $0.5 billion by 2030 with a CAGR of 9.7% from 2024 to 2030. The major drivers for this market are rising awareness of infections transmitted by mosquitoes, expanding government programs for chikungunya prevention and control, and increasing chikungunya fever prevalence.
Chikungunya Vaccine Trends and Forecast

A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below.
Chikungunya Vaccine by Segment

Chikungunya Vaccine by Segment

The study includes a forecast for the global chikungunya vaccine by type, age group, end use, and region.

Chikungunya Vaccine Market by Type [Shipment Analysis by Value from 2018 to 2030]:


• Live-Attenuated Virus Vaccines
• Inactivated Viral Vaccines
• Chimeric-Alphavirus Candidates
• Recombinant Viral Vaccines
• Others

Chikungunya Vaccine Market by Age Group [Shipment Analysis by Value from 2018 to 2030]:


• Paediatric
• Adult
• Geriatric

Chikungunya Vaccine Market by End Use [Shipment Analysis by Value from 2018 to 2030]:


• Hospital Pharmacies
• Retail Pharmacies
• Others

Chikungunya Vaccine Market by Region [Shipment Analysis by Value from 2018 to 2030]:


• North America
• Europe
• Asia Pacific
• The Rest of the World

List of Chikungunya Vaccine Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies chikungunya vaccine companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the chikungunya vaccine companies profiled in this report include-
• Takeda Pharmaceutical Company
• Valneva
• Moderna
• Emergent BioSolutions
• Bharat Biotech

Chikungunya Vaccine Market Insights

Lucintel forecasts that live-attenuated is expected to witness the highest growth over the forecast period.
Within this market, hospital pharmacy is expected to witness the higher growth.
North America is expected to witness highest growth over the forecast period.

Features of the Global Chikungunya Vaccine Market

Market Size Estimates: Chikungunya vaccine market size estimation in terms of value ($B).
Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.
Segmentation Analysis: Chikungunya vaccine market size by type, age group, end use, and region in terms of value ($B).
Regional Analysis: Chikungunya vaccine market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
Growth Opportunities: Analysis of growth opportunities in different types, age groups, end uses, and regions for the chikungunya vaccine market.
Strategic Analysis: This includes M&A, new product development, and competitive landscape of the chikungunya vaccine market.
Analysis of competitive intensity of the industry based on Porter’s Five Forces model.

FAQ

Q1. What is the chikungunya vaccine market size?
Answer: The global chikungunya vaccine market is expected to reach an estimated $0.5 billion by 2030.
Q2. What is the growth forecast for chikungunya vaccine market?
Answer: The global chikungunya vaccine market is expected to grow with a CAGR of 9.7% from 2024 to 2030.
Q3. What are the major drivers influencing the growth of the chikungunya vaccine market?
Answer: The major drivers for this market are rising awareness of infections transmitted by mosquitoes, expanding government programs for chikungunya prevention and control, and increasing chikungunya fever prevalence.
Q4. What are the major segments for chikungunya vaccine market?
Answer: The future of the chikungunya vaccine market looks promising with opportunities in the hospital pharmacy and retail pharmacy markets.
Q5. Who are the key chikungunya vaccine market companies?
Answer: Some of the key chikungunya vaccine companies are as follows:
• Takeda Pharmaceutical Company
• Valneva
• Moderna
• Emergent BioSolutions
• Bharat Biotech
Q6. Which chikungunya vaccine market segment will be the largest in future?
Answer: Lucintel forecasts that live-attenuated is expected to witness the highest growth over the forecast period.
Q7. In chikungunya vaccine market, which region is expected to be the largest in next 5 years?
Answer: North America is expected to witness highest growth over the forecast period.
Q8. Do we receive customization in this report?
Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

Q.1. What are some of the most promising, high-growth opportunities for the chikungunya vaccine market by type (live-attenuated virus vaccines, inactivated viral vaccines, chimeric-alphavirus candidates, recombinant viral vaccines, and others), age group (paediatric, adult, and geriatric), end use (hospital pharmacies, retail pharmacies, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

For any questions related to Chikungunya Vaccine Market, Chikungunya Vaccine Market Size, Chikungunya Vaccine Market Growth, Chikungunya Vaccine Market Analysis, Chikungunya Vaccine Market Report, Chikungunya Vaccine Market Share, Chikungunya Vaccine Market Trends, Chikungunya Vaccine Market Forecast, Chikungunya Vaccine Companies, write Lucintel analyst at email: helpdesk@lucintel.com. We will be glad to get back to you soon.
Table of Contents

1. Executive Summary
2. Global Chikungunya Vaccine Market : Market Dynamics
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges 
3. Market Trends and Forecast Analysis from 2018 to 2030
3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
3.2. Global Chikungunya Vaccine Market Trends (2018-2023) and Forecast (2024-2030)
3.3: Global Chikungunya Vaccine Market by Type
3.3.1: Live-Attenuated Virus Vaccines
3.3.2: Inactivated Viral Vaccines
3.3.3: Chimeric-Alphavirus Candidates
3.3.4: Recombinant Viral Vaccines
3.3.5: Others
3.4: Global Chikungunya Vaccine Market by Age Group
3.4.1: Paediatric
3.4.2: Adult
3.4.3: Geriatric
3.5: Global Chikungunya Vaccine Market by End Use
3.5.1: Hospital Pharmacies
3.5.2: Retail Pharmacies
3.5.3: Others
4. Market Trends and Forecast Analysis by Region from 2018 to 2030
4.1: Global Chikungunya Vaccine Market by Region
4.2: North American Chikungunya Vaccine Market
4.2.1: North American Chikungunya Vaccine Market by Type: Live-Attenuated Virus Vaccines, Inactivated Viral Vaccines, Chimeric-Alphavirus Candidates, Recombinant Viral Vaccines, and Others
4.2.2: North American Chikungunya Vaccine Market by End Use: Hospital Pharmacies, Retail Pharmacies, and Others
4.3: European Chikungunya Vaccine Market
4.3.1: European Chikungunya Vaccine Market by Type: Live-Attenuated Virus Vaccines, Inactivated Viral Vaccines, Chimeric-Alphavirus Candidates, Recombinant Viral Vaccines, and Others
4.3.2: European Chikungunya Vaccine Market by End Use: Hospital Pharmacies, Retail Pharmacies, and Others
4.4: APAC Chikungunya Vaccine Market
4.4.1: APAC Chikungunya Vaccine Market by Type: Live-Attenuated Virus Vaccines, Inactivated Viral Vaccines, Chimeric-Alphavirus Candidates, Recombinant Viral Vaccines, and Others
4.4.2: APAC Chikungunya Vaccine Market by End Use: Hospital Pharmacies, Retail Pharmacies, and Others
4.5: ROW Chikungunya Vaccine Market
4.5.1: ROW Chikungunya Vaccine Market by Type: Live-Attenuated Virus Vaccines, Inactivated Viral Vaccines, Chimeric-Alphavirus Candidates, Recombinant Viral Vaccines, and Others
4.5.2: ROW Chikungunya Vaccine Market by End Use: Hospital Pharmacies, Retail Pharmacies, and Others
5. Competitor Analysis
5.1: Product Portfolio Analysis
5.2: Operational Integration
5.3: Porter’s Five Forces Analysis
6. Growth Opportunities and Strategic Analysis
6.1: Growth Opportunity Analysis
6.1.1: Growth Opportunities for the Global Chikungunya Vaccine Market by Type
6.1.2: Growth Opportunities for the Global Chikungunya Vaccine Market by Age Group
6.1.3: Growth Opportunities for the Global Chikungunya Vaccine Market by End Use
6.1.4: Growth Opportunities for the Global Chikungunya Vaccine Market by Region
6.2: Emerging Trends in the Global Chikungunya Vaccine Market
6.3: Strategic Analysis
6.3.1: New Product Development
6.3.2: Capacity Expansion of the Global Chikungunya Vaccine Market
6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Chikungunya Vaccine Market
6.3.4: Certification and Licensing
7. Company Profiles of Leading Players
7.1: Takeda Pharmaceutical Company
7.2: Valneva
7.3: Moderna
7.4: Emergent BioSolutions
7.5: Bharat Biotech
.

Buy full report or by chapter as follows

Price by License Type:
[-] Hide Chapter Details
[Chapter Number] [Chapter Name] [Chapter Number Of Pages] [Chapter Price]
Title/Chapter Name Pages Price
Full Report: Chikungunya Vaccine Market Report: Trends, Forecast and Competitive Analysis to 2030 Full Report $ 4,850
A 150 Page Report
Lucintel has been in the business of market research and management consulting since 2000 and has published over 1000 market intelligence reports in various markets / applications and served over 1,000 clients worldwide. This study is a culmination of four months of full-time effort performed by Lucintel's analyst team. The analysts used the following sources for the creation and completion of this valuable report:
  • In-depth interviews of the major players in this market
  • Detailed secondary research from competitors’ financial statements and published data 
  • Extensive searches of published works, market, and database information pertaining to industry news, company press releases, and customer intentions
  • A compilation of the experiences, judgments, and insights of Lucintel’s professionals, who have analyzed and tracked this market over the years.
Extensive research and interviews are conducted across the supply chain of this market to estimate market share, market size, trends, drivers, challenges, and forecasts. Below is a brief summary of the primary interviews that were conducted by job function for this report.
 
Thus, Lucintel compiles vast amounts of data from numerous sources, validates the integrity of that data, and performs a comprehensive analysis. Lucintel then organizes the data, its findings, and insights into a concise report designed to support the strategic decision-making process. The figure below is a graphical representation of Lucintel’s research process.